These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 26163911)

  • 21. A novel mechanism for cyclosporine: inhibition of myocardial ischemia and reperfusion injury in a heterotopic rabbit heart transplant model.
    Gatewood LB; Larson DF; Bowers MC; Bond S; Cardy A; Sethi GK; Copeland JG
    J Heart Lung Transplant; 1996 Sep; 15(9):936-47. PubMed ID: 8889990
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The effect of terminal warm blood cardioplegia on myocardial ischemia/reperfusion injury].
    Gökşin I
    Anadolu Kardiyol Derg; 2006 Sep; 6(3):287. PubMed ID: 16943121
    [No Abstract]   [Full Text] [Related]  

  • 23. [Use of melatonin for cardiovascular diseases/Myocardial ischemia-reperfusion injury and melatonin].
    Vardar SA
    Anadolu Kardiyol Derg; 2006 Sep; 6(3):293; author reply 294. PubMed ID: 16943125
    [No Abstract]   [Full Text] [Related]  

  • 24. [Protective effects of 3, 6-dimethamidodibenzopyriodinium citrate on myocardial injury induced by ischemia and reperfusion in rats].
    Deng XL; Qiu PL; Liu JT; Chen SY
    Zhongguo Yao Li Xue Bao; 1993 Jul; 14(4):367-9. PubMed ID: 8249638
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Targeting histone deacetylases as a multifaceted approach to treat the diverse outcomes of stroke.
    Langley B; Brochier C; Rivieccio MA
    Stroke; 2009 Aug; 40(8):2899-905. PubMed ID: 19478231
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Histone deacetylase inhibitors in cancer therapy. A review.
    Hrabeta J; Stiborova M; Adam V; Kizek R; Eckschlager T
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2014 Jun; 158(2):161-9. PubMed ID: 24263215
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Review article: selective histone deacetylase isoforms as potential therapeutic targets in inflammatory bowel diseases.
    Felice C; Lewis A; Armuzzi A; Lindsay JO; Silver A
    Aliment Pharmacol Ther; 2015 Jan; 41(1):26-38. PubMed ID: 25367825
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The myocardial Na+/H+ exchanger: a potential therapeutic target for the prevention of myocardial ischaemic and reperfusion injury and attenuation of postinfarction heart failure.
    Karmazyn M; Sostaric JV; Gan XT
    Drugs; 2001; 61(3):375-89. PubMed ID: 11293648
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Update on the Protective Role of Regulatory T Cells in Myocardial Infarction: A Promising Therapy to Repair the Heart.
    Kaplan A; Altara R; Eid A; Booz GW; Zouein FA
    J Cardiovasc Pharmacol; 2016 Dec; 68(6):401-413. PubMed ID: 27941502
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HDAC4 degradation mediates HDAC inhibition-induced protective effects against hypoxia/reoxygenation injury.
    Du J; Zhang L; Zhuang S; Qin GJ; Zhao TC
    J Cell Physiol; 2015 Jun; 230(6):1321-31. PubMed ID: 25475100
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cardiovascular protection with sildenafil following chronic inhibition of nitric oxide synthase.
    Kukreja RC
    Br J Pharmacol; 2007 Mar; 150(5):538-40. PubMed ID: 17245364
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ticagrelor protects the heart against reperfusion injury and improves remodeling after myocardial infarction.
    Ye Y; Birnbaum GD; Perez-Polo JR; Nanhwan MK; Nylander S; Birnbaum Y
    Arterioscler Thromb Vasc Biol; 2015 Aug; 35(8):1805-14. PubMed ID: 26044583
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The protection of shenqi fuzheng injection for the lesion of myocardial ischemia/reperfusion].
    Wang ZF; Zhong L; Wen DJ
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2013 Sep; 29(5):409-10, 415. PubMed ID: 24386814
    [No Abstract]   [Full Text] [Related]  

  • 34. Inhibition of RIP1-dependent necrosis prevents adverse cardiac remodeling after myocardial ischemia-reperfusion in vivo.
    Oerlemans MI; Liu J; Arslan F; den Ouden K; van Middelaar BJ; Doevendans PA; Sluijter JP
    Basic Res Cardiol; 2012 Jul; 107(4):270. PubMed ID: 22553001
    [TBL] [Abstract][Full Text] [Related]  

  • 35. NHE-1 inhibition: from protection during acute ischaemia/reperfusion to prevention/reversal of myocardial remodelling.
    Linz WJ; Busch AE
    Naunyn Schmiedebergs Arch Pharmacol; 2003 Oct; 368(4):239-46. PubMed ID: 14504689
    [TBL] [Abstract][Full Text] [Related]  

  • 36. c-Cbl inhibition: A novel therapeutic approach for attenuating myocardial ischemia and reperfusion injury.
    Wang J; Li L; Jiang H
    Int J Cardiol; 2015; 186():50-1. PubMed ID: 25804470
    [No Abstract]   [Full Text] [Related]  

  • 37. SAHA Capture Compound--a novel tool for the profiling of histone deacetylases and the identification of additional vorinostat binders.
    Fischer JJ; Michaelis S; Schrey AK; Diehl A; Graebner OY; Ungewiss J; Horzowski S; Glinski M; Kroll F; Dreger M; Koester H
    Proteomics; 2011 Oct; 11(20):4096-104. PubMed ID: 21898820
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Zofenopril in cardiac surgery.
    Tammam Y
    Pediatr Med Chir; 2007; 29(1):23-7. PubMed ID: 17557506
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhalation of hydrogen gas reduces infarct size in the rat model of myocardial ischemia-reperfusion injury.
    Hayashida K; Sano M; Ohsawa I; Shinmura K; Tamaki K; Kimura K; Endo J; Katayama T; Kawamura A; Kohsaka S; Makino S; Ohta S; Ogawa S; Fukuda K
    Biochem Biophys Res Commun; 2008 Aug; 373(1):30-5. PubMed ID: 18541148
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeting histone deacetylases: A novel therapeutic strategy for atrial fibrillation.
    Lkhagva B; Kao YH; Chen YC; Chao TF; Chen SA; Chen YJ
    Eur J Pharmacol; 2016 Jun; 781():250-7. PubMed ID: 27089819
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.